Kallmann Syndrome
|
0.320 |
GermlineCausalMutation
|
disease |
ORPHANET |
Our studies revealed nine affected individuals from four independent families in which IHH/KS is associated with inactivating CCDC141 variants, revealing a prevalence of 3.3%.
|
28324054 |
2017 |
Kallmann Syndrome
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
Our studies revealed nine affected individuals from four independent families in which IHH/KS is associated with inactivating CCDC141 variants, revealing a prevalence of 3.3%.
|
28324054 |
2017 |
Kallmann Syndrome
|
0.320 |
SusceptibilityMutation
|
disease |
ORPHANET |
Our studies revealed nine affected individuals from four independent families in which IHH/KS is associated with inactivating CCDC141 variants, revealing a prevalence of 3.3%.
|
28324054 |
2017 |
Kallmann Syndrome
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
CCDC141 Mutation Identified in Anosmic Hypogonadotropic Hypogonadism (Kallmann Syndrome) Alters GnRH Neuronal Migration.
|
27014940 |
2016 |
Idiopathic hypogonadotropic hypogonadism
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
Our studies revealed nine affected individuals from four independent families in which IHH/KS is associated with inactivating CCDC141 variants, revealing a prevalence of 3.3%.
|
28324054 |
2017 |
Idiopathic hypogonadotropic hypogonadism
|
0.310 |
Biomarker
|
disease |
CTD_human |
|
|
|
Hypogonadotropic hypogonadism
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
CCDC141 Mutation Identified in Anosmic Hypogonadotropic Hypogonadism (Kallmann Syndrome) Alters GnRH Neuronal Migration.
|
27014940 |
2016 |
Hypogonadotropic hypogonadism
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Diastolic blood pressure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Trans-ethnic association study of blood pressure determinants in over 750,000 individuals.
|
30578418 |
2019 |
heart rate
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Multitrait genome association analysis identifies new susceptibility genes for human anthropometric variation in the GCAT cohort.
|
30166351 |
2018 |
RESTING HEART RATE
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Thirty loci identified for heart rate response to exercise and recovery implicate autonomic nervous system.
|
29769521 |
2018 |
Diastolic blood pressure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk.
|
28135244 |
2017 |
Diastolic blood pressure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide association analyses using electronic health records identify new loci influencing blood pressure variation.
|
27841878 |
2017 |
RESTING HEART RATE
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Identification of genomic loci associated with resting heart rate and shared genetic predictors with all-cause mortality.
|
27798624 |
2016 |
heart rate
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders.
|
23583979 |
2013 |
heart rate
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders.
|
23583979 |
2013 |
Systolic Pressure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide association study identifies 8 novel loci associated with blood pressure responses to interventions in Han Chinese.
|
24165912 |
2013 |
Systolic blood pressure measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide association study identifies 8 novel loci associated with blood pressure responses to interventions in Han Chinese.
|
24165912 |
2013 |
Anosmia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Ataxia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Blepharoptosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cleft Palate
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Color vision defect
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cryptorchidism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Dysarthria
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|